Published in Br J Cancer on September 26, 2006
Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC). Head Neck Oncol (2010) 1.94
ANO1 amplification and expression in HNSCC with a high propensity for future distant metastasis and its functions in HNSCC cell lines. Br J Cancer (2010) 1.38
Human papillomavirus and head and neck squamous cell carcinoma: recent evidence and clinical implications. J Dent Res (2009) 1.31
The influence of clinical and demographic risk factors on the establishment of head and neck squamous cell carcinoma cell lines. Oral Oncol (2006) 1.20
Human papillomavirus type 16 and 18 in primary lung cancers--a meta-analysis. Carcinogenesis (2009) 1.19
Knowledge about human papillomavirus and the HPV vaccine--a survey of the general population. Infect Agent Cancer (2009) 1.06
Determinants of head and neck cancer survival by race. Head Neck (2010) 1.03
Polymorphisms in DNA damage response genes and head and neck cancer risk. Biomarkers (2010) 0.98
Meta-analysis and pooled analysis of GSTM1 and CYP1A1 polymorphisms and oral and pharyngeal cancers: a HuGE-GSEC review. Genet Med (2008) 0.97
Combined p53-related genetic variants together with HPV infection increase oral cancer risk. Int J Cancer (2011) 0.96
Molecular diagnostic alterations in squamous cell carcinoma of the head and neck and potential diagnostic applications. Eur Arch Otorhinolaryngol (2013) 0.91
Prevalence of human papillomavirus (HPV) in oesophageal squamous cell carcinoma in relation to anatomical site of the tumour. PLoS One (2012) 0.90
Recurrence in oral and pharyngeal cancer is associated with quantitative MGMT promoter methylation. BMC Cancer (2009) 0.89
Epigenetic modulation of signal transduction pathways in HPV-associated HNSCC. Otolaryngol Head Neck Surg (2013) 0.81
Clinical relevance of copy number profiling in oral and oropharyngeal squamous cell carcinoma. Cancer Med (2015) 0.80
SERPINE1 and SMA expression at the invasive front predict extracapsular spread and survival in oral squamous cell carcinoma. Br J Cancer (2014) 0.79
Molecular characterization of head and neck cancer: how close to personalized targeted therapy? Mol Diagn Ther (2012) 0.78
Multicenter study of human papillomavirus and the human papillomavirus vaccine: knowledge and attitudes among people of African descent. Infect Dis Obstet Gynecol (2013) 0.75
Expression of the extracellular sulfatase SULF2 is associated with squamous cell carcinoma of the head and neck. Oncotarget (2016) 0.75
The biological significance of methylome differences in human papilloma virus associated head and neck cancer. Oncol Lett (2016) 0.75
Human papillomavirus in head and neck cancer in India: Current status and consensus recommendations. South Asian J Cancer (2017) 0.75
Analysis of enzymatically amplified beta-globin and HLA-DQ alpha DNA with allele-specific oligonucleotide probes. Nature (1986) 17.77
Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst (2000) 14.43
Improved amplification of genital human papillomaviruses. J Clin Microbiol (2000) 11.50
The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol (1995) 10.07
Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res (1988) 7.30
Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst (2003) 6.28
Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res (1996) 4.89
Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis. J Clin Oncol (2006) 4.66
E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res (1996) 4.14
Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus. J Natl Cancer Inst (2004) 3.67
Tissue microarrays for gene amplification surveys in many different tumor types. Clin Cancer Res (1999) 2.79
Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int J Cancer (2003) 2.69
Smoking and drinking in relation to cancers of the oral cavity, pharynx, larynx, and esophagus in northern Italy. Cancer Res (1990) 2.49
Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity. Proc Natl Acad Sci U S A (1996) 2.30
A subset of head and neck squamous cell carcinomas exhibits integration of HPV 16/18 DNA and overexpression of p16INK4A and p53 in the absence of mutations in p53 exons 5-8. Int J Cancer (2003) 2.24
Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control. Oncogene (2002) 2.09
Amplification of oncogenes in human cancer cells. Bioessays (1998) 1.70
Morphological and immunohistochemical evidence suggesting human papillomavirus (HPV) involvement in oral squamous cell carcinogenesis. Int J Oral Surg (1983) 1.65
Detection of human papillomavirus DNA and oncoprotein overexpression are associated with distinct morphological patterns of tonsillar squamous cell carcinoma. Am J Pathol (1998) 1.64
Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control. Cancer Res (1998) 1.63
The involvement of the chromosome 11q13 region in human malignancies: cyclin D1 and EMS1 are two new candidate oncogenes--a review. Gene (1995) 1.61
Role of tobacco and alcoholic beverages in the etiology of cancer of the oral cavity/oropharynx in Torino, Italy. Cancer Res (1989) 1.53
High-resolution mapping of the 11q13 amplicon and identification of a gene, TAOS1, that is amplified and overexpressed in oral cancer cells. Proc Natl Acad Sci U S A (2002) 1.46
Chromosomal alterations in squamous cell carcinomas of the head and neck: window to the biology of disease. Head Neck (2001) 1.44
EMS1 gene amplification correlates with poor prognosis in squamous cell carcinomas of the head and neck. Clin Cancer Res (2000) 1.44
The expression of key cell cycle markers and presence of human papillomavirus in squamous cell carcinoma of the tonsil. Head Neck (2004) 1.42
Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression. Cancer (1997) 1.34
Human papillomavirus and risk of oral cancer. Laryngoscope (1998) 1.32
PRAD-1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma. Cancer (1994) 1.23
Genetic progression and clonal relationship of recurrent premalignant head and neck lesions. Clin Cancer Res (2000) 1.15
A consistent pattern of RIN1 rearrangements in oral squamous cell carcinoma cell lines supports a breakage-fusion-bridge cycle model for 11q13 amplification. Genes Chromosomes Cancer (2000) 1.14
Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors. Laryngoscope (2002) 1.11
Comparison of the effect of smoking and alcohol drinking between oral and pharyngeal cancer. Int J Cancer (1999) 0.99
Molecular genetics of head and neck cancer. Curr Opin Oncol (1995) 0.99
Visualization of INT2 and HST1 amplification in oral squamous cell carcinomas. Genes Chromosomes Cancer (1995) 0.98
Cyclin D1 amplification correlates with early recurrence of squamous cell carcinoma of the tongue. Cancer Lett (2001) 0.90
Genetic and epigenetic alterations of 9p21 gene products in benign and malignant tumors of the head and neck. Pathol Res Pract (2003) 0.89
Prognostic value of human papillomavirus in the survival of head and neck cancer patients: an overview of the evidence. Oncol Rep (2005) 0.88
Variation of p53 mutational spectra between carcinoma of the upper and lower respiratory tract. Clin Cancer Res (1995) 0.81
Genetic alterations in squamous cell carcinomas of the hypopharynx with correlations to clinicopathological features. Oral Oncol (2002) 0.80
Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials (2000) 10.99
Etiologic and early marker studies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Control Clin Trials (2000) 5.37
Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev (2001) 3.43
Death review process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials (2000) 3.29
Effect of the age at which smoking begins on frequency of smoking in adulthood. N Engl J Med (1991) 2.96
High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. N Engl J Med (1998) 2.30
Ethnic differences in estrogen metabolism in healthy women. J Natl Cancer Inst (1996) 2.29
The epidemiology and risk factors of head and neck cancer: a focus on human papillomavirus. J Dent Res (2007) 2.24
Meta- and pooled analysis of GSTT1 and lung cancer: a HuGE-GSEC review. Am J Epidemiol (2006) 2.02
Delayed onset muscle soreness following repeated bouts of downhill running. J Appl Physiol (1985) (1985) 2.02
Etiology of Barrett's metaplasia and esophageal adenocarcinoma. Cancer Epidemiol Biomarkers Prev (1997) 1.88
Biology, cytogenetics, and sensitivity to immunological effector cells of new head and neck squamous cell carcinoma lines. Cancer Res (1989) 1.84
FHIT gene alterations in head and neck squamous cell carcinomas. Proc Natl Acad Sci U S A (1996) 1.80
Is colonoscopy needed for the nonadvanced adenoma found on sigmoidoscopy? The Polyp Prevention Trial. Gastroenterology (1998) 1.78
Re: Endocrine factors and adenocarcinoma of the lung in women. J Natl Cancer Inst (1994) 1.74
Feasibility of a large prospective study in general practice: an Italian experience. Gruppo di Studio sulla Pressione Arteriosa nell'Anziano. Br Med J (Clin Res Ed) (1987) 1.65
Tumor escape from immune recognition: lethal recurrent melanoma in a patient associated with downregulation of the peptide transporter protein TAP-1 and loss of expression of the immunodominant MART-1/Melan-A antigen. J Clin Invest (1996) 1.64
Chromosomal instability and cytoskeletal defects in oral cancer cells. Proc Natl Acad Sci U S A (2000) 1.60
Manufacturing, composition, and applications of fructose. Am J Clin Nutr (1993) 1.57
Carbamyl phosphate: an allosteric substrate for aspartate transcarbamylase of Escherichia coli. Proc Natl Acad Sci U S A (1968) 1.51
Use of calcium channel blockers and breast carcinoma risk in postmenopausal women. Cancer (1997) 1.50
Homocysteine, vitamin B12, and serum and erythrocyte folate in peritoneal dialysis and hemodialysis patients. Perit Dial Int (2000) 1.48
Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families. Blood (1998) 1.47
Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis. Am J Gastroenterol (2001) 1.47
Two new human cholangiocarcinoma cell lines and their cytogenetics and responses to growth factors, hormones, cytokines or immunologic effector cells. Int J Cancer (1992) 1.45
Risk factors for deep venous thrombosis of the upper extremities. Ann Intern Med (1997) 1.45
No association between genetic hemochromatosis and alpha1-antitrypsin deficiency. Hepatology (1996) 1.42
Lipid profile during rhGH therapy in pediatric renal transplant patients. Pediatr Transplant (2002) 1.40
Functional significance of different human CYP1A1 genotypes. Carcinogenesis (1994) 1.40
Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysis. Br J Cancer (2008) 1.38
Is shorter always better? Relative importance of questionnaire length and cognitive ease on response rates and data quality for two dietary questionnaires. Am J Epidemiol (2001) 1.35
Sagittal diameter in comparison with single slice CT as a predictor of total visceral adipose tissue volume. Int J Obes Relat Metab Disord (1998) 1.34
Mutations in coagulation factors in women with unexplained late fetal loss. N Engl J Med (2000) 1.26
Chromosomal breakpoints in cholangiocarcinoma cell lines. Genes Chromosomes Cancer (1990) 1.24
Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non-iron-related chronic liver disease. Hepatology (2001) 1.21
Isochromosome 12p mosaicism (Pallister mosaic aneuploidy or Pallister-Killian syndrome): report of 11 cases. Am J Med Genet (1987) 1.20
Risk of cerebral vein thrombosis and oral contraceptives. Lancet (1998) 1.18
Diet, metabolic polymorphisms and dna adducts: the EPIC-Italy cross-sectional study. Int J Cancer (2000) 1.16
Transcript map of the 8p23 putative tumor suppressor region. Genomics (2001) 1.15
Allelic variants of aromatase and the androgen and estrogen receptors: toward a multigenic model of prostate cancer risk. Clin Cancer Res (2001) 1.15
Current smoking, occupation, N-acetyltransferase-2 and bladder cancer: a pooled analysis of genotype-based studies. Cancer Epidemiol Biomarkers Prev (2001) 1.14
A consistent pattern of RIN1 rearrangements in oral squamous cell carcinoma cell lines supports a breakage-fusion-bridge cycle model for 11q13 amplification. Genes Chromosomes Cancer (2000) 1.14
Interaction between the G20210A mutation of the prothrombin gene and oral contraceptive use in deep vein thrombosis. Arterioscler Thromb Vasc Biol (1999) 1.12
Patient satisfaction with screening flexible sigmoidoscopy. Arch Intern Med (2000) 1.10
The relationship between TP53 mutations and overexpression of p53 and prognosis in malignant gliomas of childhood. Cancer Res (1997) 1.10
Muscle soreness and serum creatine kinase activity following isometric, eccentric, and concentric exercise. Int J Sports Med (1986) 1.07
Death from cardiovascular disease in Italy, 1972-1981: decline in mortality rates and possible causes. Int J Epidemiol (1988) 1.06
Coming to terms with the era of AIDS: attitudes of physicians in U.S. residency programs. J Gen Intern Med (1993) 1.05
Tumor escape from immune recognition: loss of HLA-A2 melanoma cell surface expression is associated with a complex rearrangement of the short arm of chromosome 6. Clin Cancer Res (1996) 1.05
Reliability of health belief indexes: confirmatory factor analysis in sex, race, and age subgroups. Health Serv Res (1987) 1.03
Distinct distribution of HPV types among cancer-free Afro-Caribbean women from Tobago. Biomarkers (2007) 1.01
Hypertension, heart rate, use of antihypertensives, and incident prostate cancer. Ann Epidemiol (2001) 1.01
Adult hemoglobins are synthesized in murine fetal hepatic erythropoietic cells. Blood (1983) 1.01
The ulcerogenic and protective action of rice and rice fractions in experimental peptic ulceration. Clin Sci (Lond) (1987) 1.01
Relationship between genotype and function of the human CYP1A1 gene. J Toxicol Environ Health (1993) 1.01
Recognition of oxidized DNA bases by sera of patients with inflammatory diseases. Free Radic Biol Med (1993) 1.00
MTHFR C677T polymorphism, GSTM1 deletion and male infertility: a possible suggestion of a gene-gene interaction? Biomarkers (2006) 0.99
A molecular basis of peptic ulceration due to diet. Br J Exp Pathol (1986) 0.99
Gene amplification and overexpression of protein phosphatase 1alpha in oral squamous cell carcinoma cell lines. Oncogene (2006) 0.98
Visualization of INT2 and HST1 amplification in oral squamous cell carcinomas. Genes Chromosomes Cancer (1995) 0.98
Tumor necrosis factor alpha promoter polymorphisms influence the phenotypic expression of hereditary hemochromatosis. Blood (2001) 0.98
Fine mapping of an imprinted gene for familial nonchromaffin paragangliomas, on chromosome 11q23. Am J Hum Genet (1997) 0.98
Duplication of proximal 15q as a cause of Prader-Willi syndrome. Am J Med Genet (1987) 0.97
Persistent infection of rabbits with bovine leukemia virus associated with development of immune dysfunction. J Virol (1989) 0.97
Overexpression of KLF13 and FGFR3 in oral cancer cells. Cytogenet Genome Res (2010) 0.96
Left ventricular structure and function in normotensive adolescents with a genetic predisposition to hypertension. Am Heart J (1986) 0.96
Medical dramas on television: a brief guide for educators. Med Teach (2012) 0.96
Systemic absorption of lithium following ingestion of a lithium button battery. Hum Exp Toxicol (2004) 0.95
Increased susceptibility to nonalcoholic fatty liver disease in heterozygotes for the mutation responsible for hereditary hemochromatosis. Dig Liver Dis (2003) 0.95
Relation of stress and anxiety to oral lichen planus. Oral Surg Oral Med Oral Pathol (1986) 0.95
A novel CYP1A1 gene polymorphism in African-Americans. Carcinogenesis (1993) 0.94
Chromosomal instability in oral cancer cells. J Dent Res (2005) 0.94
The dual origins of the olivocochlear bundle in the albino rat. J Comp Neurol (1983) 0.93
Sigmoidoscopy use among primary care physicians. Prev Med (1995) 0.93
Feasibility of a long-term low-sodium diet in mild hypertension. J Hum Hypertens (1992) 0.93
Deficiency in myosin light-chain phosphorylation causes cytokinesis failure and multipolarity in cancer cells. Oncogene (2010) 0.93
Ecologic study of lung cancer risk factors in the U.S. and Japan, with special reference to smoking and diet. Jpn J Cancer Res (1992) 0.92
Interaction between smoking, GSTM1 deletion and colorectal cancer: results from the GSEC study. Biomarkers (2003) 0.92
In vitro quantification of anti-red blood cell antibody production in idiopathic autoimmune haemolytic anaemia: effect of mitogen and cytokine stimulation. Br J Haematol (2000) 0.91
Injuries and risk factors in a 100-mile (161-km) infantry road march. Prev Med (1999) 0.91
Serum autoantibodies recognizing 5-hydroxymethyl-2'-deoxyuridine, an oxidized DNA base, as biomarkers of cancer risk in women. Cancer Epidemiol Biomarkers Prev (1998) 0.90
Glutathione S-transferase M1 polymorphism and lung cancer risk in African-Americans. Carcinogenesis (2000) 0.90
The identification of different structural classes of nucleic acids by electrophoresis in polyacrylamide gels of different concentration. Biochim Biophys Acta (1973) 0.89
A non-classical translocation involving 17q12 (retinoic acid receptor alpha) in acute promyelocytic leukemia (APML) with atypical features. Leukemia (1994) 0.89
Malignancy after retinoblastoma: secondary cancer or recurrence? Hum Pathol (1997) 0.89
Association of 8p23 deletions with poor survival in head and neck cancer. Otolaryngol Head Neck Surg (2001) 0.89
Allele frequencies of polymorphisms of TNFA, IL-6, IL-10 and IFNG in an Italian Caucasian population. Eur J Immunogenet (2002) 0.88
Hemolytic uremic syndrome and cattle. Clin Nephrol (2003) 0.88
Medulloblastoma and glioblastoma multiforme in a patient with Turcot syndrome: a case report. Surg Neurol (1998) 0.87
Bone mineral density and risk of breast cancer: differences by family history of breast cancer. Study of Osteoporotic Fractures Research Group. Am J Epidemiol (1998) 0.87
Inverted duplication pattern in anaphase bridges confirms the breakage-fusion-bridge (BFB) cycle model for 11q13 amplification. Cytogenet Genome Res (2007) 0.87
Acquired monosomy 7 in donor cells in a patient treated for acute lymphoblastic leukemia with bone marrow transplantation. Cancer Genet Cytogenet (1997) 0.87
Loss of heterozygosity of the short arm of chromosomes 3 and 9 in oral cancer. Int J Cancer (1996) 0.87
Review and pooled analysis of studies on MTHFR C677T polymorphism and esophageal cancer. Toxicol Lett (2008) 0.87
Genetic metabolic polymorphisms and the risk of cancer: a review of the literature. Biomarkers (1996) 0.87
Blood donors with 'medium' or 'minor' risk factors for human immunodeficiency virus infection: are they eligible for donation? Haematologica (2000) 0.87
International collaborative study on genetic susceptibility to environmental carcinogens. Cancer Epidemiol Biomarkers Prev (1999) 0.87